Dr. Shehriyar Mehershahi, MD

Dr. Mehershahi practices at CHRISTUS Mother Frances Hospital - Tyler in Tyler, Texas, part of CHRISTUS Health.

Dr. Mehershahi's NPI, 1720463524, was assigned on July 22, 2015. Dr. Mehershahi graduated from Dow University of Health Sciences in 2013. Dr. Mehershahi's Virginia license number on file is 0101274011.

Dr. Mehershahi's primary practice is CHRISTUS Mother Frances Hospital - Tyler, at 800 East Dawson, Tyler, TX 75701 in Smith County. The practice phone is (903) 593-8441.

Dr. Mehershahi's primary practice is CHRISTUS Mother Frances Hospital - Tyler in Tyler, Texas, part of CHRISTUS Health. Dr. Mehershahi is also affiliated with CHRISTUS St. Michael Hospital. The medical group on file is CHRISTUS Trinity Clinic. Dmand AI also links Dr. Mehershahi to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehershahi practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mehershahi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mehershahi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mehershahi's licenses on file in 3 states: Virginia, Texas and New York.

Dmand AI lists colonoscopy, esophagus, stomach, or upper small intestine surgery and upper GI endoscopy among the conditions Dr. Mehershahi treats.

CMS data shows 1,436 Medicare services from Dr. Mehershahi across 21 procedure codes in 2024, for 504 Medicare patients. Medicare paid $123,905 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 504 Medicare patients who saw Dr. Mehershahi in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehershahi's median patient age at 65, with 54% women.

In 2024, Dr. Mehershahi wrote 236 Medicare Part D claims for 192 patients. 79% of them were for generic drugs. CMS names the drug for 192 of them, across 5 drugs with 11 or more claims each, at $3,688 in total drug cost. In 2023, CMS named 27 claims across 1 drug.

Dr. Mehershahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 660 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mehershahi, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 28 papers to Dr. Mehershahi, published from 2018 to 2024. 2020 was the busiest year, with 10. Dr. Mehershahi has published most often in Case Rep Gastroenterol. Dr. Mehershahi's most frequent co-authors are Harish Kishorkumar Patel, MD, Ahmed Mahros Kamal Baiomi, MD and Kishore Kumar, MD.

CMS Open Payments shows 91 general payments to Dr. Mehershahi from 9 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 72% of the total. Boston Scientific Corporation paid the most, $6,246.

Dr. Mehershahi graduated from Dow University of Health Sciences in 2013.

Dr. Mehershahi is in network with 21 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.